| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | $29,968,780 | 11,939,753 | Commodore Capital LP | 02 Feb 2026 | |||
| TCG Crossover GP II, LLC | 6.9% | $21,767,809 | 7,915,567 | Chen Yu | 03 Feb 2026 | |||
| Qatar Investment Authority | 6.2% | $19,451,597 | 7,073,308 | Qatar Investment Authority | 04 Feb 2026 | |||
| MORGAN STANLEY | 6% | $11,199,351 | 4,461,893 | Morgan Stanley | 31 Dec 2025 | |||
| Avidity Partners Management LP | 4.2% | $6,903,688 | 2,841,024 | Avidity Partners Management LP | 31 Dec 2024 | |||
| FMR LLC | 0.4% | -98% | $824,113 | -$15,183,078 | 312,164 | -95% | FMR LLC | 28 Nov 2025 |
| JANUS HENDERSON GROUP PLC | 0% | $43,349 | 17,839 | JANUS HENDERSON GROUP PLC | 31 Dec 2024 |
As of 31 Dec 2025, 112 institutional investors reported holding 35,133,059 shares of Perspective Therapeutics, Inc. - Common Stock (CATX). This represents 47% of the company’s total 74,364,883 outstanding shares.
The largest institutional shareholders of Perspective Therapeutics, Inc. - Common Stock (CATX) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.1% | 4,559,977 | +4.4% | 0% | $12,539,939 |
| MORGAN STANLEY | 6% | 4,474,522 | +62% | 0% | $12,304,936 |
| VANGUARD GROUP INC | 4.7% | 3,490,658 | +1.5% | 0% | $9,599,310 |
| Avidity Partners Management LP | 4.3% | 3,210,733 | +7.2% | 2.5% | $8,829,516 |
| Nicholson Wealth Management Group, LLC | 2.2% | 1,617,993 | -0.02% | 2.6% | $4,449,481 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,414,522 | -1.3% | 0% | $3,890,676 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 1,406,374 | -45% | 0% | $3,867,528 |
| Nuveen, LLC | 1.7% | 1,274,007 | -2.6% | 0% | $3,503,519 |
| TWO SIGMA INVESTMENTS, LP | 1.6% | 1,198,644 | +131% | 0% | $3,296,271 |
| STATE STREET CORP | 1.5% | 1,141,247 | +3.3% | 0% | $3,138,429 |
| Patient Square Capital LP | 1.5% | 1,132,815 | +224% | 0.67% | $3,115,241 |
| Hills Bank & Trust Co | 1.3% | 938,200 | -4.2% | 0.15% | $2,580,050 |
| UBS Group AG | 1.2% | 926,331 | +44% | 0% | $2,547,410 |
| TWO SIGMA ADVISERS, LP | 0.89% | 663,830 | +64% | 0% | $1,825,533 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.72% | 535,477 | -0.06% | 0% | $1,472,562 |
| NORTHERN TRUST CORP | 0.59% | 439,214 | -6.7% | 0% | $1,207,839 |
| BANK OF AMERICA CORP /DE/ | 0.57% | 424,519 | -46% | 0% | $1,167,427 |
| MARSHALL WACE, LLP | 0.55% | 406,732 | 0% | $1,118,514 | |
| WealthPlan Investment Management, LLC | 0.54% | 404,071 | 0% | 0.07% | $1,111,195 |
| RENAISSANCE TECHNOLOGIES LLC | 0.47% | 352,493 | 0% | $969,356 | |
| SPHERA FUNDS MANAGEMENT LTD. | 0.47% | 349,973 | -31% | 0.2% | $962,426 |
| Walleye Capital LLC | 0.44% | 328,667 | -40% | 0.01% | $903,834 |
| Point72 Asset Management, L.P. | 0.42% | 314,180 | +610% | 0% | $863,995 |
| FMR LLC | 0.41% | 307,055 | -97% | 0% | $844,401 |
| Affinity Asset Advisors, LLC | 0.4% | 300,000 | 0% | 0.06% | $825,000 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 35,133,059 | $96,616,093 | -$20,139,755 | $2.75 | 112 |
| 2025 Q3 | 42,524,179 | $145,860,657 | +$1,461,871 | $3.43 | 103 |
| 2025 Q2 | 42,232,957 | $145,284,060 | +$679,387 | $3.44 | 95 |
| 2025 Q1 | 44,107,303 | $93,948,628 | -$10,507,953 | $2.13 | 109 |
| 2024 Q4 | 47,101,393 | $150,249,113 | -$74,925,753 | $3.19 | 133 |
| 2024 Q3 | 49,033,906 | $653,981,361 | +$116,633,428 | $13.35 | 124 |
| 2024 Q2 | 38,531,736 | $384,149,816 | +$383,863,185 | $9.97 | 102 |